Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8400)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 27, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song K, Han C, Dash S, Balart LA, Wu T. MiR-122 in hepatitis B virus and hepatitis C virus dual infection. World J Hepatol 2015; 7(3): 498-506 [PMID: 25848473 DOI: 10.4254/wjh.v7.i3.498] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i3/498.htm |
| Number | Citing Articles |
| 1 |
Miao Li, Tongtong Zhang, Lifei Zhu, Rui Wang, Yiguang Jin. Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway. International Journal of Pharmaceutics 2017; 528(1-2): 163 doi: 10.1016/j.ijpharm.2017.06.005
|
| 2 |
Hongqiang Du, Shuang Cui, Yunfei Li, Guang Yang, Peiyan Wang, Erol Fikrig, Fuping You, Sebastien Pfeffer. MiR-221 negatively regulates innate anti-viral response. PLOS ONE 2018; 13(8): e0200385 doi: 10.1371/journal.pone.0200385
|
| 3 |
Dorota Zarębska-Michaluk, Robert Flisiak, Marta Flisiak-Jackiewicz. Management of hepatitis B and hepatitis C coinfection: an expert review. Expert Review of Anti-infective Therapy 2020; 18(10): 1033 doi: 10.1080/14787210.2020.1776112
|
| 4 |
Hong-Yan Sun, Yu-Ling Su, Pin-Hong Li, Jia-Yang He, He-Jia Chen, Gang Wang, Shao-Wen Wang, Xiao-Hong Huang, You-Hua Huang, Qi-Wei Qin. The Roles of Epinephelus coioides miR-122 in SGIV Infection and Replication. Marine Biotechnology 2021; 23(2): 294 doi: 10.1007/s10126-021-10023-w
|
| 5 |
Rasoul Mirzaei, Sajad Karampoor, Nadezhda Lenoktovna Korotkova. The emerging role of miRNA-122 in infectious diseases: Mechanisms and potential biomarkers. Pathology - Research and Practice 2023; 249: 154725 doi: 10.1016/j.prp.2023.154725
|
| 6 |
Huan Zhou, Bin Wang, Ying-xi Yang, Qiu-jin Jia, Ao Zhang, Zhong-wen Qi, Jun-ping Zhang. Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7159592
|
| 7 |
Shengtao Fan. Molecular Biology of Hand-Foot-Mouth Diseases. 2024; : 95 doi: 10.1007/978-981-99-9660-5_4
|
| 8 |
Fedra Mokhtari, Hami Kaboosi, Seyed Reza Mohebbi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Circulating Plasma miR-122 and miR-583 Levels Are Involved in Chronic Hepatitis B Virus Pathogenesis and Serve As Novel Diagnostic Biomarkers. Genetic Testing and Molecular Biomarkers 2023; 27(8): 232 doi: 10.1089/gtmb.2023.0013
|
| 9 |
Michael P. Trinh, Jocelyn G. Carballo, Gary B. Adkins, Kaizhu Guo, Wenwan Zhong. Physical and chemical template-blocking strategies in the exponential amplification reaction of circulating microRNAs. Analytical and Bioanalytical Chemistry 2020; 412(11): 2399 doi: 10.1007/s00216-020-02496-w
|
| 10 |
Anne De Monte, Johan Courjon, Rodolphe Anty, Eric Cua, Alissa Naqvi, Véronique Mondain, Jacqueline Cottalorda, Laurence Ollier, Valérie Giordanengo. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge. Journal of Clinical Virology 2016; 78: 27 doi: 10.1016/j.jcv.2016.02.026
|
| 11 |
Ewa Ostrycharz, Beata Hukowska-Szematowicz. Micro-Players of Great Significance—Host microRNA Signature in Viral Infections in Humans and Animals. International Journal of Molecular Sciences 2022; 23(18): 10536 doi: 10.3390/ijms231810536
|
| 12 |
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; : 290 doi: 10.2174/9789815123432123010013
|
| 13 |
Gabriele Fabbri, Ilaria Mastrorosa, Alessandra Vergori, Valentina Mazzotta, Carmela Pinnetti, Susanna Grisetti, Mauro Zaccarelli, Adriana Ammassari, Andrea Antinori. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2287-y
|
| 14 |
M. E. Khodjaeva, A. S. Khikmatullaeva, N. S. Ibadullaeva, M. A. Abdukadirova, K. E. Novak, E. V. Esaulenko. MicroRNA-122: assessment of diagnostic significance in HDV infection. Journal Infectology 2024; 16(1): 56 doi: 10.22625/2072-6732-2024-16-1-56-61
|
| 15 |
Tongtong Zhang, Lifei Zhu, Miao Li, Yuzhen Hu, Erfeng Zhang, Qingcheng Jiang, Guang Han, Yiguang Jin. Inhalable Andrographolide-β-cyclodextrin Inclusion Complexes for Treatment of Staphylococcus aureus Pneumonia by Regulating Immune Responses. Molecular Pharmaceutics 2017; 14(5): 1718 doi: 10.1021/acs.molpharmaceut.6b01162
|
| 16 |
Janani Srinivasa Vasudevan, Akshay Kanakan, Shweta Sahni, Rajesh Pandey. Rna-Based Regulation in Human Health and Disease. 2020; : 327 doi: 10.1016/B978-0-12-817193-6.00014-5
|
| 17 |
Sonam Gupta, Shama Parveen. Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach. Archives of Virology 2024; 169(2) doi: 10.1007/s00705-023-05955-8
|
| 18 |
Xuewei Huang, Weiye Liu. Role of microRNAs in host defense against porcine reproductive and respiratory syndrome virus infection: a hidden front line. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1376958
|
| 19 |
Mengjiao Fu, Bin Wang, Xiang Chen, Zhiyuan He, Yongqiang Wang, Xiaoqi Li, Hong Cao, Shijun J. Zheng, Susana López. MicroRNA gga-miR-130b Suppresses Infectious Bursal Disease Virus Replication via Targeting of the Viral Genome and Cellular Suppressors of Cytokine Signaling 5. Journal of Virology 2018; 92(1) doi: 10.1128/JVI.01646-17
|